Page 50 - Insurance Times September 2019
P. 50

cial AI partner for India’s Central Tuberculosis Division. The  developer or the medical practitioner?” Movdawalla of EY
         company will work to address multiple challenges around  India asks.
         TB care, such as case-load estimation at the district level
         using risk and transmission factors, and prioritisation of TB  In such a situation, partnering with larger tech firms will
                                                              make it easier for startups to gain acceptance and access to
         patients for health workers by classifying the risk of them
                                                              clients. For instance, technology leader Google is looking to
         dropping off from treatment.
                                                              develop an AI solution that is robust enough to accurately
         The company is also creating a smartphone-based virtual  detect diabetic retinopathy using low-quality images.
         weighing machine to allow frontline workers to screen for  The company has been working with Indian hospitals to
         babies with low birth weight, in order to improve child  better train its AI system. Last year, the AI solution began
         health. One of the biggest challenges these startups face
                                                              giving preliminary results to help doctors make a more
         is gaining scientific acceptance, as most solutions that they  accurate diagnosis, after Google partnered leading eye care
         develop need USFDA approval. For many startups, market  chains Narayana Nethralaya, Aravind Eye Hospital and
         presence and reach also remains a challenge.
                                                              Sankara Nethralaya. “Today, we have volumes of data avail-
                                                              able. We can draw insights from this data and loop it back
         Partnerships with large hospitals or corporates seem to be  into the decision-making process.
         the best option to ensure their solution reaches as many
         people as possible. “While most of the work in coming up  We now have tools to make sense of both structured and un-
         with low-cost, noninvasive solutions is being driven by  structured data,” said Barik of Deloitte India. A lot will, how-
         startups, there are still grey areas. Who is responsible for  ever, depend on how effectively this data can translate into an
         an incorrect diagnosis because of a glitch – the software  AI-powered healthcare solution. (Source: Economics Times)
















































          50  The Insurance Times, September 2019
   45   46   47   48   49   50   51   52   53   54   55